Clozapine-induced myocarditis, a widely overlooked adverse reaction (Q38417079)

2 September 2017

1 reference

title

Clozapine-induced myocarditis, a widely overlooked adverse reaction (English)

1 reference

2 September 2017

0 references

1 reference

K J Ronaldson

1

1 reference

2 September 2017

P B Fitzgerald

series ordinal

2

1 reference

2 September 2017

J J McNeil

series ordinal

3

1 reference

2 September 2017

language of work or name

English

0 references

publication date

11 April 2015

1 reference

Acta Psychiatrica Scandinavica

2 September 2017

published in

1 reference

2 September 2017

volume

132

1 reference

2 September 2017

issue

4

1 reference

2 September 2017

page(s)

231-240

1 reference

The choice of antipsychotic drugs for schizophrenia

2 September 2017

cites work

1 reference

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

21 January 2018

1 reference

Clozapine for the treatment of schizophrenia

21 January 2018

1 reference

Myocarditis and cardiomyopathy associated with clozapine

21 January 2018

1 reference

Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003

21 January 2018

1 reference

Myocarditis during clozapine treatment

21 January 2018

1 reference

Adverse cardiac effects associated with clozapine

21 January 2018

1 reference

Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy

21 January 2018

1 reference

Clozapine Tissue Concentrations following an Apparent Suicidal Overdose of Clozaril®

21 January 2018

1 reference

Myocarditis under therapy with clozapine

21 January 2018

1 reference

Clozapine rechallenge after myocarditis

21 January 2018

1 reference

Clozapine associated pericarditis and elevated troponin I.

21 January 2018

1 reference

Clozapine-associated cardiomyopathy

21 January 2018

1 reference

Sudden cardiac death due to hypersensitivity myocarditis during clozapine treatment.

21 January 2018

1 reference

Clozapine-induced hypersensitivity myocarditis

21 January 2018

1 reference

Acute myocarditis associated with clozapine.

21 January 2018

1 reference

Clozapine-induced myocarditis after long-term treatment: case presentation and clinical perspectives

21 January 2018

1 reference

Monitoring of clozapine-induced myocarditis

21 January 2018

1 reference

Clozapine rechallenge after myocarditis

21 January 2018

1 reference

Cardiovascular magnetic resonance in mild to moderate clozapine-induced myocarditis: is there a role in the absence of electrocardiographic and echocardiographic abnormalities?

21 January 2018

1 reference

The safety and tolerability of clozapine in aged patients: a retrospective clinical file review.

21 January 2018

1 reference

Successful clozapine retrial after suspected myocarditis

21 January 2018

1 reference

Clozapine rechallenge following clozapine-induced pericarditis

21 January 2018

1 reference

Clozapine-induced myocarditis: 2 case reports

21 January 2018

1 reference

Clozapine-induced cardiomyopathy: a first case in Japan

21 January 2018

1 reference

Clozapine-induced myocarditis: is mandatory monitoring warranted for its early recognition?

21 January 2018

1 reference

21 January 2018

1 reference

Myocarditis and cardiomyopathy associated with clozapine use in the United States

21 January 2018

1 reference

Echocardiographic monitoring for clozapine cardiac toxicity: lessons from real-world experience

21 January 2018

1 reference

Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study

21 January 2018

1 reference

A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls

21 January 2018

1 reference

Clozapine and sudden death.

21 January 2018

1 reference

Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine

21 January 2018

1 reference

Chart review for potential features of myocarditis, pericarditis, and cardiomyopathy in children and adolescents treated with clozapine

21 January 2018

1 reference

Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: a case-control study

21 January 2018

1 reference

Mortality in current and former users of clozapine.

21 January 2018

1 reference

Diagnostic characteristics of clozapine-induced myocarditis identified by an analysis of 38 cases and 47 controls

21 January 2018

1 reference

Side effects of clozapine

21 January 2018

1 reference

The characteristics of clozapine-induced fever

21 January 2018

1 reference

Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia--a retrospective study of 387 patients

21 January 2018

1 reference

Increases in C-reactive protein may predict recurrence of clozapine-induced fever

21 January 2018

1 reference

Management of clozapine-induced fever: a case of continued therapy throughout fever

21 January 2018

1 reference

Clozapine-induced elevated C-reactive protein and fever mimic infection

21 January 2018

1 reference

Management of clozapine-induced fever in a child

21 January 2018

1 reference

Reason for clozapine cessation

21 January 2018

1 reference

Schizophrenia, neuroleptic medication and mortality

21 January 2018

1 reference

Atypical antipsychotic drugs and the risk of sudden cardiac death

21 January 2018

1 reference

21 January 2018

1 reference

Update on the adverse effects of clozapine: focus on myocarditis

21 January 2018

1 reference

Reasons for discontinuing clozapine: matched, case-control comparison with risperidone long-acting injection

21 January 2018

1 reference

21 January 2018

1 reference

Suspected clozapine poisoning in the UK/Eire, 1992-2003.

21 January 2018

1 reference

Second-generation antipsychotic medications and risk of pneumonia in schizophrenia.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ACPS.12416

1 reference

2 September 2017

1 reference